Day Traders, Penny Stocks, Stock Options, Futures and Forex

ProtoKinetix, Inc. is a research and product development stage company. The Company owns the world-wide rights to a family of anti-aging glycoproteins, trademarked as AAGPs. In scientific tests AAGPs have demonstrated the ability to improve the health and extend the life of biologically sensitive cells, which have been subjected to severe stress conditions under laboratory controlled test conditions. AAGPs are stable and non-toxic. As of December 31, 2008, the Company had not sold any products. The Company is also researching the benefits and feasibility of synthesized Antifreeze Glycoproteins (AFGP).

PKTX

RSI LINE @ 48.66

MAC D is above the signal

HIST GRAM is building

BB is positive @ .029

SLOPE is up .0002

Its on the dip as of now

could be a good opportunity

Keep an eye on it for positive movement







BUSINESS MODEL >>

ProtoKinetix is building value for investors through licensing and joint ventures with business partners, utilizing our internationally patented technology– which is comprised of a family of glycoprotein compounds – targeting biotechnology applications where existing and developing businesses have requirements that AAGPs™ – anti-aging glycopeptides – will dramatically improve.

The biotechnology business is often subject to expensive and time consuming regulatory processes. Our approach is to expedite the development of our technology primarily through business relationships that provide us with leading-edge technical and marketing expertise to expedite the time lines to place products on the shelf.

ProtoKinetix is not about building a business with “bricks and mortar.” We believe there are so many AAGP™ applications that can best be reached through strategic business relationships.

We assess each opportunity with return on investment as the priority. Defining and measuring each agreement based upon corporate investment, time line to market, strength of the organization within a specific market segment and marketing strengths.

As we build the value of AAGP™ we are also taking steps to generate revenue through sales of products in markets that do not require regulatory oversight.

Stock to watch!!!!
PKTX: PROTOKINETIX INC (PKTX.OB)
:PKTX - SharpCharts Workbench : StockCharts.com
IMO, this stock could very well be a money maker!!! It's at .081 right about now and could fly through the first resistance of .086!!! It holds a good support .07.... the MACDline is above signal and can very well continue moving north...
Keep both eyes on this stock folks!!!
good luck on all your trades!!!

Industry sources estimate that the skincare market in the USA, including both mass and prestige, will reach $7.2 billion by 2010, driven in part by expected double-digit growth of anti-aging products, which is likely to become the second largest category behind hand & body lotions in the industry.

According to the Johnson and Johnson Annual Report, the global skin care and cosmetics market is already running easily in the tens of billions at some $43 billion dollars per year.

Everyone is talking about anti-aging; and in the skin care business it`s about healthier, younger looking skin.

ProtoKinetix is Reviewing Major European Proposals


PROTOKINETIX INC. (PKTX:OTCBB)
VANCOUVER, Dec 15, 2009 (BUSINESS WIRE) -- ProtoKinetix Inc. (PKTX) has been approached by a European biopharma investment group with a series of proposals to develop commercial partnerships in the pharmaceutical/cosmetic arenas. In order to support these initiatives, it has been strongly suggested that our European technology (AAGP(TM)) should be more visibly showcased within the European community. This would include an awareness program leading up to a sponsorship for a listing on the AIM, London Stock Exchange.
ProtoKinetix believes that these events are natural synergies due to the strong European origins of the AAGP(TM) family of molecules. AAGP(TM) was first created in the laboratories of the University of Rouen, France. Human embryonic stem cell preservation was successfully tested at the University of Helsinki, Finland. The University of Bordeaux proved the ability of AAGP(TM) to defend skin cells from a wide range of hostile conditions. The National Institute of Chemistry, in France, showed that these molecules were non-toxic in standard concentrations.

ProtoKinetix' President and CEO states that, "in addition to the proposals currently being evaluated, the company has a number of excellent opportunities to enter into new collaborations with world leading biotechnology investigators and companies to expand the use and applications of the AAGP(TM) family of molecules. Though these European collaborations and partnerships, we are confident of both financial and scientific success".

About ProtoKinetix

ProtoKinetix, Inc. is a biotechnology company that has developed and patented a family of synthetic anti-aging glycoproteins (AAGP(TM)) for medicine and the biotechnology and cosmetic industries. PKTX is currently in dialogue with major corporations and institutions who have contacted the company about the broad range of applications for AAGP(TM) products.

For more detailed information, please visit our website at: Protokinetix, anti-aging glycoproteins, AAGP, cell survival

The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements. Some information included in this press release contains statements that are forward-looking. Such forward-looking information involves significant risks and uncertainties that could affect anticipated results in the future and, accordingly, these results may differ materially from those expressed in any forward-looking statements made by or on behalf of the Company. For a description of additional risks and uncertainties, please refer to the Company's filings with the Securities and Exchange Commission.

PKTX
volume spike on a big up day on Friday followed by low volume and a very small down day on Monday would lead me to believe there was some profit taking, The big gap down yesterday on another light volume day,imo, means that investors are waiting for it to break $0.10 to the upside to get back in. Closing on the highs yesterday could cause the gap to close this morning since any sell pressure yesterday failed at an apparent $0.08 support level. Once the resistance level of $0.10 is broken it should become a new support level

(PKTX) has been approached by a European biopharma investment group with a series of proposals to develop commercial partnerships in the pharmaceutical/cosmetic arenas. This should only make the company grow in value. With this news this stock will make a run today. IMO

(PKTX.OB)... PROTOKINETIX INC..
Thank you for the great news!!
With this, this company should begin to show more appreciation from the previous HOD of .081.... This stock's historicals proves that it could very well reach record high resistance and IMO, now is the time to get in!!!..
StockCharts.com

The President and CEO states that, “in addition to the proposals currently being evaluated, the company has a number of excellent opportunities to enter into new collaborations with world leading biotechnology investigators and companies to expand the uses!!!
Good trading everyone!~!!!

PKTX

Straight out of the box in the green

+23.46%

RSI LINE @ 70.53 in power and rising

MAC D pulled away from the signal

I believe PKTX will take off

Keep an eye on it

PKTX ProtoKinetix, Inc. looking to expand it's market base to include a listing on the AIM, London Stock Exchange. Great stock with awesome potential. IMO. Get this one on your radar. Good luck!!!